HoneyNaps
PrivateLast Round
Series B
May 7, 2024
Total Funding Raised
$16.2M
Company Overview
HoneyNaps operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series B round in May 2024.
HoneyNaps is a digital health company that develops AI-driven sleep disorder diagnostic software and bio-signal monitoring platforms.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Medical Devices, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HoneyNaps Comparables
Compare HoneyNaps with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurobit | 90% | |
| EnsoData | 87% | |
| Beacon Biosignals | 79% |
For institutional investors. Book with your work email.
HoneyNaps Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 7, 2024 | ||||
| Series A | Jan 1, 2021 |
For institutional investors. Book with your work email.
HoneyNaps Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| iM Investment Partners | Series B |
| QUAD Investment Management | Series B |
| Government of South Korea | Seed |
| Industrial Bank of Korea | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 5, 2025
Participated in the 18th World Sleep Congress in Singapore.
- Aug 19, 2025
Launched cloud version of SOMNUM software at SLEEP 2025 conference.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 23, 2026
HoneyNaps USA, Inc. and Uppsala University are set to partner in a Eurostars project with South Korean and Swedish institutions to develop and validate a non-invasive platform for monitoring intracranial pressure and sleep status, announced on Oct 23rd '26.
- partners_withOct 23, 2026
On Oct 23rd '26, HoneyNaps USA, Inc. partners with Dankook in a Eurostars project to develop and validate an integrated platform for non-invasive monitoring of intracranial pressure and sleep status.
- is_developingOct 2, 2026
HoneyNaps USA, Inc. develops a wireless, AI-enabled polysomnography system that combines four skin-mounted sensor patches with AI-based sleep analysis for hospital and potential home use.
- is_developingSep 4, 2026
HoneyNaps USA, Inc. develops a next-generation Wireless PSG system that uses four compact skin patches and AI-powered analysis to improve patient comfort and clinical efficiency in polysomnography in Massachusetts on Sep 4th '26.
- launchesSep 4, 2026
HoneyNaps USA, Inc. launched wireless polysomnography system generation on Sep 4th '26.
For institutional investors. Book with your work email.
HoneyNaps Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HoneyNaps's valuation, stock price, and market status.
Is HoneyNaps a public or private company?
HoneyNaps is a private company.
What is the current stock price of HoneyNaps?
HoneyNaps is a private company, so its shares have no public market price. Caplight tracks HoneyNaps's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HoneyNaps worth (valuation)?
Valuation information for HoneyNaps is not publicly available.
Can I buy HoneyNaps stock?
HoneyNaps shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HoneyNaps's last funding round?
HoneyNaps's most recent funding round was Series B on May 7, 2024.
Who are the main investors in HoneyNaps?
Key investors in HoneyNaps include iM Investment Partners, QUAD Investment Management, Government of South Korea, Industrial Bank of Korea.
Will HoneyNaps IPO soon?
No public IPO plans have been announced for HoneyNaps.
How can I track HoneyNaps secondary market activity?
Caplight tracks bids, offers, and trades in HoneyNaps's shares on secondary markets.